Restricted accessResearch articleFirst published online 2024-08
Targeted Next-Generation Sequencing Analysis Reveals a Novel Genetic Variant in MYO6 Gene in an Indian Family with Postlingual Nonsyndromic Hearing Loss
Hereditary nonsyndromic hearing loss (NSHL) is an extremely heterogeneous disorder, both genetically and clinically. Myosin VI (MYO6) pathogenic variations have been reported to cause both prelingual and postlingual forms of NSHL. Postlingual autosomal dominant cases are often overlooked for genetic etiology in clinical setups. In this study, we used next-generation sequencing (NGS)-based targeted deafness gene panel assay to identify the cause of postlingual hearing loss in an Indian family.
Methods:
The proband and his father from a multigenerational Indian family affected by postlingual hearing loss were examined via targeted capture of 129 deafness genes, after excluding gap junction protein beta 2 (GJB2) pathogenic variants by Sanger sequencing. NGS data analysis and co-segregation of the candidate variants in the family were carried out. The variant effect was predicted by in silico tools and interpreted following American College of Medical Genetics and Genomics-Association for Molecular Pathology guidelines.
Results:
A novel heterozygous transversion c.3225T>G, p.(Tyr1075*) in MYO6 gene was identified as the disease-causing variant in this family. This stop-gained variant is predicted to form a truncated myosin VI protein, which is devoid of crucial cargo-binding domain. PCR-RFLP screening in 200 NSHL cases and 200 normal-hearing controls showed the absence of this variant indicating its de novo nature in the population. Furthermore, we reviewed MYO6 variants reported from various populations to date.
Conclusions:
To the best of our knowledge, this is the first family with MYO6-associated hearing loss from an Indian population. The study also highlights the importance of deafness gene panels in molecular diagnosis of GJB2-negative pedigrees, contributing to genetic counseling in the affected families.
Get full access to this article
View all access options for this article.
References
1.
AdhikaryB, BankuraB, BiswasS, et al.Absence of KCNQ4 mutation in Bengali families with ADNSHL originated from West Bengal, India. Int J Pediatr Otorhinolaryngol, 2017; 100:35-38; doi: 10.1016/j.ijporl.2017.06.004
2.
AhmedZM, MorellRJ, RiazuddinS, et al.Mutations of MYO6 are associated with recessive deafness, DFNB37. Am J Hum Genet, 2003; 72(5):1315-1322; doi: 10.1086/375122
3.
AlimardaniM, HosseiniSM, KhanianiMS, et al.Targeted mutation analysis of the SLC26A4, MYO6, PJVK and CDH23 genes in Iranian patients with AR Nonsyndromic Hearing Loss. Fetal Pediatr Pathol, 2019; 38(2):93-102; doi: 10.1080/15513815.2018.1547336
4.
ArdenSD, TumbarelloDA, ButtT, et al.Loss of cargo binding in the human myosin VI deafness mutant (R1166X) leads to increased actin filament binding. Biochem J, 2016; 473(19):3307-3319; doi: 10.1042/bcj20160571
5.
AvrahamKB, HassonT, SteelKP, et al.The mouse Snell’s waltzer deafness gene encodes an unconventional myosin required for structural integrity of inner ear hair cells. Nat Genet, 1995; 11(4):369-375; doi: 10.1038/ng1295-369
6.
BrownsteinZ, Abu-RayyanA, Karfunkel-DoronD, et al.Novel myosin mutations for hereditary hearing loss revealed by targeted genomic capture and massively parallel sequencing. Eur J Hum Genet, 2014; 22(6):768-775; doi: 10.1038/ejhg.2013.232
7.
BuonfiglioPI, BruqueCD, LoterszteinV, et al.Predicting pathogenicity for novel hearing loss mutations based on genetic and protein structure approaches. Sci Rep, 2022; 12(1):301; doi: 10.1038/s41598-021-04081-2
8.
ChengJ, ZhouX, LuY, et al.Exome sequencing identifies a novel frameshift mutation of MYO6 as the cause of autosomal dominant nonsyndromic hearing loss in a Chinese family. Ann Hum Genet, 2014; 78(6):410-423; doi: 10.1111/ahg.12084
9.
ChoiBY, ParkG, GimJ, et al.Diagnostic application of targeted resequencing for familial nonsyndromic hearing loss. PLoS One, 2013; 8(8):e68692; doi: 10.1371/journal.pone.0068692
10.
FriedmanTB, BelyantsevaIA, FrolenkovGI. Myosins and hearing. Adv Exp Med Biol, 2020; 1239:317-330; doi: 10.1007/978-3-030-38062-5_13
11.
HaileLM, KamenovK, BriantPS, etal. Hearing loss prevalence and years lived with disability, 1990-2019: Findings from the Global Burden of Disease Study 2019. Lancet, 2021; 397(10278):996-1009; doi: 10.1016/s0140-6736(21)00516-x
12.
HilgertN, TopsakalV, van DintherJ, et al.A splice-site mutation and overexpression of MYO6 cause a similar phenotype in two families with autosomal dominant hearing loss. Eur J Hum Genet, 2008; 16(5):593-602; doi: 10.1038/sj.ejhg.5202000
13.
JainA, BhoyarRC, PandhareK, et al.IndiGenomes: A comprehensive resource of genetic variants from over 1000 Indian genomes. Nucleic Acids Res, 2021; 49(D1):D1225-d1232; doi: 10.1093/nar/gkaa923
14.
JiH, LuJ, WangJ, et al.Combined examination of sequence and copy number variations in human deafness genes improves diagnosis for cases of genetic deafness. BMC Ear Nose Throat Disord, 2014; 14:9; doi: 10.1186/1472-6815-14-9
15.
KapplerJA, StarrCJ, ChanDK, et al.A nonsense mutation in the gene encoding a zebrafish myosin VI isoform causes defects in hair-cell mechanotransduction. Proc Natl Acad Sci U S A, 2004; 101(35):13056-13061; doi: 10.1073/pnas.0405224101
16.
KwonTJ, OhSK, ParkHJ, et al.The effect of novel mutations on the structure and enzymatic activity of unconventional myosins associated with autosomal dominant non-syndromic hearing loss. Open Biol, 2014; 4(7); doi: 10.1098/rsob.140107
17.
LahiriDK, NurnbergerJI.Jr., A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res, 1991; 19(19):5444; doi: 10.1093/nar/19.19.5444
18.
MelchiondaS, AhituvN, BiscegliaL, et al.MYO6, the human homologue of the gene responsible for deafness in Snell’s waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am J Hum Genet, 2001; 69(3):635-640; doi: 10.1086/323156
19.
MiyagawaM, NaitoT, NishioSY, et al.Targeted exon sequencing successfully discovers rare causative genes and clarifies the molecular epidemiology of Japanese deafness patients. PLoS One, 2013; 8(8):e71381; doi: 10.1371/journal.pone.0071381
20.
MohiddinSA, AhmedZM, GriffithAJ, et al.Novel association of hypertrophic cardiomyopathy, sensorineural deafness, and a mutation in unconventional myosin VI (MYO6). J Med Genet, 2004; 41(4):309-314; doi: 10.1136/jmg.2003.011973
21.
OkaSI, DayTF, NishioSY, et al.Clinical characteristics and in vitro analysis of MYO6 variants causing late-onset progressive hearing loss. Genes (Basel), 2020; 11(3); doi: 10.3390/genes11030273
22.
OonkAM, LeijendeckersJM, LammersEM, et al.Progressive hereditary hearing impairment caused by a MYO6 mutation resembles presbyacusis. Hear Res, 2013; 299:88-98; doi: 10.1016/j.heares.2012.12.015
23.
PengJ, XiangJ, JinX, et al.VIP-HL: Semi-automated ACMG/AMP variant interpretation platform for genetic hearing loss. Hum Mutat, 2021; 42(12):1567-1575; doi: 10.1002/humu.24277
24.
RichardsS, AzizN, BaleS, et al.Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015; 17(5):405-424; doi: 10.1038/gim.2015.30
25.
RouxI, HosieS, JohnsonSL, et al.Myosin VI is required for the proper maturation and function of inner hair cell ribbon synapses. Hum Mol Genet, 2009; 18(23):4615-4628; doi: 10.1093/hmg/ddp429
26.
Sampaio-SilvaJ, BatissocoAC, Jesus-SantosR, et al.Exome sequencing identifies a novel nonsense mutation of MYO6 as the cause of deafness in a Brazilian Family. Ann Hum Genet, 2018; 82(1):23-34; doi: 10.1111/ahg.12213
27.
SanggaardKM, KjaerKW, EibergH, et al.A novel nonsense mutation in MYO6 is associated with progressive nonsyndromic hearing loss in a Danish DFNA22 family. Am J Med Genet A, 2008; 146a(8):1017-1025; doi: 10.1002/ajmg.a.32174
28.
SatoO, WhiteHD, InoueA, et al.Human deafness mutation of myosin VI (C442Y) accelerates the ADP dissociation rate. J Biol Chem, 2004; 279(28):28844-28854; doi: 10.1074/jbc.M314332200
29.
SchefferDI, ShenJ, CoreyDP, et al.Gene expression by mouse inner ear hair cells during development. J Neurosci, 2015; 35(16):6366-6380; doi: 10.1523/jneurosci.5126-14.2015
30.
SchrauwenI, SommenM, CorneveauxJJ, et al.A sensitive and specific diagnostic test for hearing loss using a microdroplet PCR-based approach and next generation sequencing. Am J Med Genet A, 2013; 161a(1):145-152; doi: 10.1002/ajmg.a.35737
31.
SeilerC, Ben-DavidO, SidiS, et al.Myosin VI is required for structural integrity of the apical surface of sensory hair cells in zebrafish. Dev Biol, 2004; 272(2):328-338; doi: 10.1016/j.ydbio.2004.05.004
32.
SekiY, MiyasakaY, SuzukiS, et al.A novel splice site mutation of myosin VI in mice leads to stereociliary fusion caused by disruption of actin networks in the apical region of inner ear hair cells. PLoS One, 2017; 12(8):e0183477; doi: 10.1371/journal.pone.0183477
33.
SekiY, ShitaraH, IshiiR, et al.Myosin VI haploinsufficiency reduced hearing ability in mice. Neuroscience, 2021; 478:100-111; doi: 10.1016/j.neuroscience.2021.09.023
34.
SelfT, SobeT, CopelandNG, et al.Role of myosin VI in the differentiation of cochlear hair cells. Dev Biol, 1999; 214(2):331-341; doi: 10.1006/dbio.1999.9424
35.
ShearerAE, DeLucaAP, HildebrandMS, et al.Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci U S A, 2010; 107(49):21104-21109; doi: 10.1073/pnas.1012989107
36.
SheffieldAM, SmithRJH. The epidemiology of deafness. Cold Spring Harb Perspect Med, 2019; 9(9); doi: 10.1101/cshperspect.a033258
37.
SinghPK, GhoshM, SharmaS, et al.Identification of a novel homozygous mutation in transmembrane channel like 1 (TMC1) gene, one of the second-tier hearing loss genes after GJB2 in India. Indian J Med Res, 2017; 145(4):492-497; doi: 10.4103/ijmr.IJMR_397_15
38.
TalebiF, MardasiFG, AslJM, et al.Next-generation sequencing identifies three novel missense variants in ILDR1 and MYO6 genes in an Iranian family with hearing loss with review of the literature. Int J Pediatr Otorhinolaryngol, 2017; 103:103-108; doi: 10.1016/j.ijporl.2017.09.018
39.
TianT, LuY, YaoJ, et al.Identification of a novel MYO6 mutation associated with autosomal dominant non-syndromic hearing loss in a Chinese family by whole-exome sequencing. Genes Genet Syst, 2018; 93(5):171-179; doi: 10.1266/ggs.18-00006
40.
VanniyaSP, ChandruJ, JeffreyJM, et al.PNPT1, MYO15A, PTPRQ, and SLC12A2-associated genetic and phenotypic heterogeneity among hearing impaired assortative mating families in Southern India. Ann Hum Genet, 2022; 86(1):1-13; doi: 10.1111/ahg.12442
41.
VolkAE, Lang-RothR, YigitG, et al.A novel MYO6 splice site mutation causes autosomal dominant sensorineural hearing loss type DFNA22 with a favourable outcome after cochlear implantation. Audiol Neurootol, 2013; 18(3):192-199; doi: 10.1159/000350246
42.
VonaB, MüllerT, NandaI, et al.Targeted next-generation sequencing of deafness genes in hearing-impaired individuals uncovers informative mutations. Genet Med, 2014; 16(12):945-953; doi: 10.1038/gim.2014.65
43.
WangJ, ShenJ, GuoL, et al.A humanized mouse model, demonstrating progressive hearing loss caused by MYO6 p.C442Y, is inherited in a semi-dominant pattern. Hear Res, 2019; 379:79-88; doi: 10.1016/j.heares.2019.04.014
44.
WellsAL, LinAW, ChenLQ, et al.Myosin VI is an actin-based motor that moves backwards. Nature, 1999; 401(6752):505-508; doi: 10.1038/46835
45.
XiaoQ, XuZ, XueY, et al.Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor. Sci Transl Med, 2022; 14(654):eabn0449; doi: 10.1126/scitranslmed.abn0449
46.
YanD, Kannan-SundhariA, VishwanathS, et al.The genetic basis of nonsyndromic hearing loss in indian and pakistani populations. Genet Test Mol Biomarkers, 2015; 19(9):512-527; doi: 10.1089/gtmb.2015.0023
47.
YanD, TekinD, BademciG, et al.Spectrum of DNA variants for non-syndromic deafness in a large cohort from multiple continents. Hum Genet, 2016; 135(8):953-961; doi: 10.1007/s00439-016-1697-z
48.
YangT, WeiX, ChaiY, et al.Genetic etiology study of the non-syndromic deafness in Chinese Hans by targeted next-generation sequencing. Orphanet J Rare Dis, 2013; 8:85; doi: 10.1186/1750-1172-8-85
49.
Zazo SecoC, WesdorpM, FeenstraI, et al.The diagnostic yield of whole-exome sequencing targeting a gene panel for hearing impairment in The Netherlands. Eur J Hum Genet, 2017; 25(3):308-314; doi: 10.1038/ejhg.2016.182
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
